Endoscopic Devices - Malaysia | Statista Market Forecast

In Malaysia, revenue in the Endoscopic Devices market market is projected to reach US$206.40m in 2024.
This revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 8.57%, which will result in a market volume of US$311.30m by 2029.
In comparison with the global market, the majority of revenue will be generated the United States, amounting to US$10.39bn in 2024.
In Malaysia, the growing emphasis on minimally invasive surgeries is driving innovation and adoption of advanced endoscopic devices within the medical technology market.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Malaysia is witnessing moderate growth, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and heightened awareness of minimally invasive procedures among healthcare professionals and patients.

Customer preferences: Consumers in Malaysia are increasingly favoring minimally invasive surgical options, leading to a growing demand for advanced endoscopic devices. This shift is partly influenced by a rising awareness of the benefits of quicker recovery times and reduced hospital stays. Additionally, the aging population is driving preferences towards procedures that minimize trauma and enhance quality of life. Cultural emphasis on holistic health and wellness is prompting patients to seek innovative technologies that align with their desire for effective, less invasive treatment options.

Trends in the market: In Malaysia, the Endoscopic Devices Market is experiencing significant growth as healthcare providers increasingly adopt minimally invasive surgical techniques. This trend is fueled by rising patient awareness of the benefits associated with quicker recovery times and reduced hospital stays. The aging population is also driving demand for innovative endoscopic solutions that minimize trauma and improve overall quality of life. Furthermore, a cultural focus on holistic health is encouraging patients to seek cutting-edge technologies that offer effective, minimally invasive treatment options, presenting substantial opportunities for industry stakeholders to innovate and expand their offerings.

Local special circumstances: In Malaysia, the Endoscopic Devices Market is shaped by unique local factors, including a diverse population that values both modern and traditional healthcare practices. The country's strategic location as a medical tourism hub promotes the adoption of advanced endoscopic technologies, attracting international patients seeking high-quality, minimally invasive procedures. Regulatory frameworks that encourage innovation while ensuring safety standards also play a crucial role in market dynamics. Additionally, public health initiatives aimed at enhancing surgical care accessibility further stimulate demand for endoscopic solutions, creating a favorable environment for growth.

Underlying macroeconomic factors: The Endoscopic Devices Market in Malaysia is significantly influenced by macroeconomic factors such as overall economic stability, healthcare expenditure, and demographic trends. The country's steady GDP growth fosters investment in advanced medical technologies, while rising disposable incomes enable patients to seek high-quality healthcare services. Furthermore, government initiatives aimed at boosting healthcare infrastructure and attracting foreign investment enhance market potential. The increasing prevalence of lifestyle-related diseases further drives demand for minimally invasive procedures, positioning endoscopic devices as essential tools in modern medical practice. Additionally, global supply chain dynamics impact the availability and cost of these devices, shaping market competitiveness.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.